Related Experiment Video
Updated: Oct 15, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
[Therapy of Helicobacter pylori infection]
1Universitätsklinikum der Otto-von-Guerike-Universität Magdeburg. gerhard.treiber@medizin.uni-magdeburg.de
Abstract:
H. pylori eradication remains standard treatment for peptic ulcer disease. Until now, other indications like non-ulcer dyspepsia, reflux esophagitis, or concomitant medication with non-steroidal antirheumatics are not approved according to actual guidelines and these patients should be managed on an individual basis only. One week triple therapy consisting of a proton-pump inhibitor (PPI), a macrolide antibiotic (clarithromycin), and a imidazole antibiotic (metronidazole) or amoxicillin, given bid. Quadruple therapy including PPI, bismuth, tetracycline and metronidazole should be reserved to eradication failures.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis II: Pathophysiology
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
